199 related articles for article (PubMed ID: 22382829)
1. [Development of polaprezinc research].
Takei M
Yakugaku Zasshi; 2012; 132(3):271-7. PubMed ID: 22382829
[TBL] [Abstract][Full Text] [Related]
2. Effects of polaprezinc on morphological change of the tongue in zinc-deficient rats.
Kinomoto T; Sawada M; Ohnishi Y; Yamaguchi T; Tsuge S; Ogawa S; Washizuka M; Minaguchi J; Mera Y; Takehana K
J Oral Pathol Med; 2010 Sep; 39(8):617-23. PubMed ID: 21054547
[TBL] [Abstract][Full Text] [Related]
3. Effect of polaprezinc on taste disorders in zinc-deficient rats.
Hamano H; Yoshinaga K; Eta R; Emori Y; Kawasaki D; Iino Y; Sawada M; Kuroda H; Takei M
Biofactors; 2006; 28(3-4):185-93. PubMed ID: 17473379
[TBL] [Abstract][Full Text] [Related]
4. Polaprezinc, a zinc compound, is distributed to the lingual epithelium and increases its zinc concentration in zinc-deficient rats.
Hamano H; Yoshinaga K; Tanaka T; Eta R; Horii T; Kawabata Y; Furuta S; Takei M
Life Sci; 2009 Nov; 85(21-22):759-64. PubMed ID: 19846043
[TBL] [Abstract][Full Text] [Related]
5. Residence time of polaprezinc (zinc L-carnosine complex) in the rat stomach and adhesiveness to ulcerous sites.
Furuta S; Toyama S; Miwa M; Itabashi T; Sano H; Yoneta T
Jpn J Pharmacol; 1995 Apr; 67(4):271-8. PubMed ID: 7650862
[TBL] [Abstract][Full Text] [Related]
6. A Review of Zinc-L-Carnosine and Its Positive Effects on Oral Mucositis, Taste Disorders, and Gastrointestinal Disorders.
Hewlings S; Kalman D
Nutrients; 2020 Feb; 12(3):. PubMed ID: 32121367
[TBL] [Abstract][Full Text] [Related]
7. [Involvement of zinc in taste disturbance occurring during treatment for malignant tumor in the chest and the effects of polaprezinc oral disintegrating tablets (a retrospective study)].
Nakata Y; Hirashima T; Kondou Y; Tokuoka Y; Imazato H; Iwata K; Oomori Y; Yamato A; Shimizu S; Nagao S; Matsui K; Abe N
Gan To Kagaku Ryoho; 2008 Jun; 35(6):955-9. PubMed ID: 18633224
[TBL] [Abstract][Full Text] [Related]
8. Zinc-L-Carnosine Complex (Polaprezinc) for the Treatment of Binge Eating: Three Case Reports.
Sakae K; Yanagisawa H
J Clin Psychopharmacol; 2017 Dec; 37(6):734-736. PubMed ID: 28926352
[No Abstract] [Full Text] [Related]
9. Effect of polaprezinc (N-(3-aminopropionyl)-L-histidinato zinc), a novel antiulcer agent containing zinc, on cellular proliferation: role of insulin-like growth factor I.
Seto K; Yoneta T; Suda H; Tamaki H
Biochem Pharmacol; 1999 Jul; 58(2):245-50. PubMed ID: 10423164
[TBL] [Abstract][Full Text] [Related]
10. Disposition of polaprezinc (zinc L-carnosine complex) in rat gastrointestinal tract and effect of cimetidine on its adhesion to gastric tissues.
Furuta S; Toyama S; Miwa M; Sano H
J Pharm Pharmacol; 1995 Aug; 47(8):632-6. PubMed ID: 8583362
[TBL] [Abstract][Full Text] [Related]
11. Polaprezinc attenuates cyclophosphamide-induced cystitis and related bladder pain in mice.
Murakami-Nakayama M; Tsubota M; Hiruma S; Sekiguchi F; Matsuyama K; Kimura T; Moriyama M; Kawabata A
J Pharmacol Sci; 2015 Feb; 127(2):223-8. PubMed ID: 25727961
[TBL] [Abstract][Full Text] [Related]
12. Oral treatment of pressure ulcers with polaprezinc (zinc L-carnosine complex): 8-week open-label trial.
Sakae K; Yanagisawa H
Biol Trace Elem Res; 2014 Jun; 158(3):280-8. PubMed ID: 24691900
[TBL] [Abstract][Full Text] [Related]
13. Polaprezinc prevents ongoing thioacetamide-induced liver fibrosis in rats.
Kono T; Asama T; Chisato N; Ebisawa Y; Okayama T; Imai K; Karasaki H; Furukawa H; Yoneda M
Life Sci; 2012 Jan; 90(3-4):122-30. PubMed ID: 22100444
[TBL] [Abstract][Full Text] [Related]
14. Tissue distribution of polaprezinc in rats determined by the double tracer method.
Furuta S; Suzuki M; Toyama S; Miwa M; Sano H
J Pharm Biomed Anal; 1999 Mar; 19(3-4):453-61. PubMed ID: 10704111
[TBL] [Abstract][Full Text] [Related]
15. Ulcerogenic and healing impairing actions of monochloramine in rat stomachs: effects of zinc L-carnosine, polaprezinc.
Nishiwaki H; Kato S; Sugamoto S; Umeda M; Morita H; Yoneta T; Takeuchi K
J Physiol Pharmacol; 1999 Jun; 50(2):183-95. PubMed ID: 10424716
[TBL] [Abstract][Full Text] [Related]
16. A zinc-containing compound, Polaprezinc, is effective for patients with taste disorders: randomized, double-blind, placebo-controlled, multi-center study.
Sakagami M; Ikeda M; Tomita H; Ikui A; Aiba T; Takeda N; Inokuchi A; Kurono Y; Nakashima M; Shibasaki Y; Yotsuya O
Acta Otolaryngol; 2009 Oct; 129(10):1115-20. PubMed ID: 19037756
[TBL] [Abstract][Full Text] [Related]
17. Irritant action of monochloramine in rat stomachs: effects of zinc L-carnosine (polaprezinc).
Nishiwaki H; Kato S; Takeuchi K
Gen Pharmacol; 1997 Nov; 29(5):713-8. PubMed ID: 9347315
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and Safety of Polaprezinc (Zinc Compound) on Zinc Deficiency: A Systematic Review and Dose-Response Meta-Analysis of Randomized Clinical Trials Using Individual Patient Data.
Furihata K; Tsuchikawa M; Miwa T; Naito Y; Oba K; Sakagami M
Nutrients; 2020 Apr; 12(4):. PubMed ID: 32316581
[TBL] [Abstract][Full Text] [Related]
19. Insulin-like growth factor I plays a role in gastric wound healing: evidence using a zinc derivative, polaprezinc, and an in vitro rabbit wound repair model.
Watanabe S; Wang XE; Hirose M; Kivilioto T; Osada T; Miwa H; Oide H; Kitamura T; Yoneta T; Seto K; Sato N
Aliment Pharmacol Ther; 1998 Nov; 12(11):1131-8. PubMed ID: 9845403
[TBL] [Abstract][Full Text] [Related]
20. Polaprezinc, a gastroprotective agent: attenuation of monochloramine-evoked gastric DNA fragmentation.
Suzuki H; Mori M; Seto K; Nagahashi S; Kawaguchi C; Morita H; Suzuki M; Miura S; Yoneta T; Ishii H
J Gastroenterol; 1999; 34 Suppl 11():43-6. PubMed ID: 10616765
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
